NED Series by Forvis Mazars
A new space for Non-Executive Directors to connect, challenge and grow.
Lesson for NEDs in the age of ROAI: return on artificial intelligence
Join our next NED Series event to hear how two FTSE top three companies, HSBC and AstraZeneca, have tackled one of the most pressing boardroom questions today: how to move AI from hype to measurable value.
Date23 June 2026 | Time17:30 – 20:00 | LocationLondon Forvis Mazars office, 30 Old Bailey |
Uncover how leading FTSE companies are proving ROI on AI
AI is moving faster than boards can govern it. Rapid advances in technology, increasing regulatory scrutiny and rising expectations around productivity are creating unprecedented pressure on boards to move beyond experimentation and demonstrate real value. Among the noise and hype, there is genuine opportunity. So how can NEDs help their organisations turn AI ambition into measurable outcomes, while managing risks that are still developing?
This session is designed for NEDs who want practical insights into how boards can drive real value from AI. Drawing on real-world experience from two of the world’s most well-known brands, the session will cover:
- Board-level AI governance and oversight.
- AI risk, assurance and regulation.
- What boards should demand in terms of productivity, outcomes, ROI and accountability.
- Implementation and workforce impact - capability, change and mitigation.
Our expert speakers will share first-hand perspectives on how AI is being governed, implemented and measured at scale, followed by open discussion and audience Q&A.
Created in response to feedback from NEDs across our network, the series offers topical insights, practical briefings and space to share experiences with fellow board members. It’s a chance to learn from peers grappling with similar challenges and to explore how boards can provide confident oversight as AI scales.
Why attend?
The NED Series by Forvis Mazars is a growing community, exploring the issues that matter most to today’s boards. From AI and climate risk to cybersecurity and stakeholder expectations, each session is shaped by NEDs themselves, addressing real boardroom challenges.
Agenda
17:30 – Registration & networking
18:10 – Welcome & opening remarks
18:15 – Keynotes
18:35 – Panel discussion: featuring industry experts and NEDs
18:50 – Audience Q&A 19:10 – Networking, drinks & canapes
Speakers
David NewbyIntegrated Transformation Lead, Office of Applied Artificial Intelligence, HSBC David has led complex global transformation programmes across HSBC and is currently supporting the bank’s Office of Applied Artificial Intelligence, focused on the scaled deployment of AI across the organisation. He will share how a global financial services group is approaching AI governance and value creation, including some practical challenges of moving from experimentation to enterprise-wide adoption. |
Olawale AlimiSenior Director, R&D Data & AI Policy (Data & AI Risk and Compliance), AstraZeneca Olawale leads AI governance, risk and compliance within AstraZeneca’s R&D function, with responsibility for shaping and embedding ethical and responsible AI frameworks at scale. Drawing on AstraZeneca’s experience, he will share lessons on operationalising AI governance, managing regulatory and ethical risk, and supporting innovation. |
They will be joined by Sofia Ihsan - Head of AI Consulting at Forvis Mazars, alongside fellow NEDs and subject matter specialists, to explore what effective AI oversight and ROI look like in practice.
Key contact
